Thomas George Larson

Array ( [id] => 4181408 [patent_doc_number] => 06037463 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Enzymatic RNA molecules that cleave mutant N-RAS' [patent_app_type] => 1 [patent_app_number] => 8/862270 [patent_app_country] => US [patent_app_date] => 1997-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8007 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037463.pdf [firstpage_image] =>[orig_patent_app_number] => 862270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3949490 [patent_doc_number] => 05998603 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => '4\'-desmethyl nucleoside analogs, and oligomers thereof' [patent_app_type] => 1 [patent_app_number] => 8/809239 [patent_app_country] => US [patent_app_date] => 1997-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21123 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998603.pdf [firstpage_image] =>[orig_patent_app_number] => 809239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3992483 [patent_doc_number] => 05919677 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Eukaryotic and retroviral antisense initiator elements' [patent_app_type] => 1 [patent_app_number] => 8/853703 [patent_app_country] => US [patent_app_date] => 1997-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 9319 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919677.pdf [firstpage_image] =>[orig_patent_app_number] => 853703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924039 [patent_doc_number] => 05952201 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Method of preparing oligonucleotide probes or primers, vector therefor and use thereof' [patent_app_type] => 1 [patent_app_number] => 8/836222 [patent_app_country] => US [patent_app_date] => 1997-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 4666 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952201.pdf [firstpage_image] =>[orig_patent_app_number] => 836222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4152121 [patent_doc_number] => 06107078 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Ribozymes with optimized hybridizing arms, stems, and loops, tRNA embedded ribozymes and compositions thereof' [patent_app_type] => 1 [patent_app_number] => 8/765257 [patent_app_country] => US [patent_app_date] => 1997-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 25 [patent_no_of_words] => 22028 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 244 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107078.pdf [firstpage_image] =>[orig_patent_app_number] => 765257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4293225 [patent_doc_number] => 06184037 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell' [patent_app_type] => 1 [patent_app_number] => 8/850597 [patent_app_country] => US [patent_app_date] => 1997-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 18626 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184037.pdf [firstpage_image] =>[orig_patent_app_number] => 850597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4004710 [patent_doc_number] => 05888737 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Adaptor-based sequence analysis' [patent_app_type] => 1 [patent_app_number] => 8/842608 [patent_app_country] => US [patent_app_date] => 1997-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11954 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 233 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888737.pdf [firstpage_image] =>[orig_patent_app_number] => 842608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4117312 [patent_doc_number] => 06046307 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Modulation of mammalian telomerase by peptide nucleic acids' [patent_app_type] => 1 [patent_app_number] => 8/838545 [patent_app_country] => US [patent_app_date] => 1997-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 24766 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/046/06046307.pdf [firstpage_image] =>[orig_patent_app_number] => 838545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3766921 [patent_doc_number] => 05849497 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Specific inhibition of the polymerase chain reaction using a non-extendable oligonucleotide blocker' [patent_app_type] => 1 [patent_app_number] => 8/832449 [patent_app_country] => US [patent_app_date] => 1997-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 7572 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849497.pdf [firstpage_image] =>[orig_patent_app_number] => 832449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4112559 [patent_doc_number] => 06045998 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Technique for differential display' [patent_app_type] => 1 [patent_app_number] => 8/832021 [patent_app_country] => US [patent_app_date] => 1997-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 10755 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 342 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/045/06045998.pdf [firstpage_image] =>[orig_patent_app_number] => 832021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4239532 [patent_doc_number] => 06080727 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Oligonucleotide treatments and compositions for human melanoma' [patent_app_type] => 1 [patent_app_number] => 8/827036 [patent_app_country] => US [patent_app_date] => 1997-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 15701 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080727.pdf [firstpage_image] =>[orig_patent_app_number] => 827036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4129967 [patent_doc_number] => 06146877 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Identification of the progression elevated gene-3 and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/821818 [patent_app_country] => US [patent_app_date] => 1997-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19006 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/146/06146877.pdf [firstpage_image] =>[orig_patent_app_number] => 821818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3808633 [patent_doc_number] => 05831058 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Human GDP dissociation stimulating protein gene' [patent_app_type] => 1 [patent_app_number] => 8/820170 [patent_app_country] => US [patent_app_date] => 1997-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 23877 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/831/05831058.pdf [firstpage_image] =>[orig_patent_app_number] => 820170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3994759 [patent_doc_number] => 05892024 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Bifunctional nucleosides, oligomers thereof, and methods of making and using the same' [patent_app_type] => 1 [patent_app_number] => 8/816708 [patent_app_country] => US [patent_app_date] => 1997-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8566 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 205 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/892/05892024.pdf [firstpage_image] =>[orig_patent_app_number] => 816708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4123135 [patent_doc_number] => 06127116 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Functional DNA clone for hepatitis C virus (HCV) and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/811566 [patent_app_country] => US [patent_app_date] => 1997-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 48 [patent_no_of_words] => 49865 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127116.pdf [firstpage_image] =>[orig_patent_app_number] => 811566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4004692 [patent_doc_number] => 05888736 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Method, compositions and kit for detection and identification of microorganisms' [patent_app_type] => 1 [patent_app_number] => 8/807138 [patent_app_country] => US [patent_app_date] => 1997-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20489 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 280 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888736.pdf [firstpage_image] =>[orig_patent_app_number] => 807138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3949476 [patent_doc_number] => 05998602 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'RNase L activators and antisense oligonucleotides effective to treat RSV infections' [patent_app_type] => 1 [patent_app_number] => 8/801898 [patent_app_country] => US [patent_app_date] => 1997-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 32 [patent_no_of_words] => 15572 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998602.pdf [firstpage_image] =>[orig_patent_app_number] => 801898 [rel_patent_id] =>[rel_patent_doc_number] =>)